CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis

Norikuni Kawanaka1, Masahiro Yamamura, Tetsushi Aita

  • 1Department of Medicine and Clinical Science, Graduate School of Medicine and Dentistry, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

Arthritis and Rheumatism
|October 18, 2002
PubMed
Abstract

Insights

CD14+,CD16+ monocytes are elevated in rheumatoid arthritis (RA) patients, correlating with disease activity. Cytokine-induced maturation of these monocytes may drive persistent joint inflammation in RA.

Area of Science:

  • Immunology
  • Rheumatology

Background:

  • CD14+,CD16+ monocytes are a minor subset in human peripheral blood (PB).
  • This monocyte subset has been implicated in various inflammatory diseases.

Purpose of the Study:

  • To investigate the role of CD14+,CD16+ monocytes in joint inflammation in rheumatoid arthritis (RA).

Main Methods:

  • Flow cytometry measured CD14, CD16, CCR1, CCR5, and ICAM-1 expression on monocytes.
  • ELISA measured cytokine concentrations (TGF-beta1, M-CSF, IL-10) and soluble CD14 (sCD14).
  • In vitro culture assessed CD16 induction on RA monocytes by cytokines.

Main Results:

  • RA patients showed a significantly higher frequency of CD14+,CD16+ blood monocytes compared to healthy controls.
  • Increased CD16+ monocyte frequency correlated with active RA disease markers and higher cytokine/sCD14 levels.
  • CD14+,CD16+ monocytes expressed higher levels of CCR1, CCR5, and ICAM-1, particularly in active RA.

Conclusions:

  • Elevated CD14+,CD16+ monocytes in RA patients suggest their involvement in disease pathogenesis.
  • Cytokine-induced maturation of monocytes before joint entry may contribute to persistent RA joint inflammation.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...